RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm∗†

ABSTRACT:

SUBMITTER: Kok C 

PROVIDER: S-EPMC12311592 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature